awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37709182-7BC78FA6-7957-4D1E-BFC2-F5A67961AD6D
Q37709182-7BC78FA6-7957-4D1E-BFC2-F5A67961AD6D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37709182-7BC78FA6-7957-4D1E-BFC2-F5A67961AD6D
EGFR kinase inhibitors and gastric acid suppressants in EGFR-mutant NSCLC: a retrospective database analysis of potential drug interaction.
P2860
Q37709182-7BC78FA6-7957-4D1E-BFC2-F5A67961AD6D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37709182-7BC78FA6-7957-4D1E-BFC2-F5A67961AD6D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2d80fb71ebff940e921bb8163f4a346e3e122738
P2860
Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations.